161 related articles for article (PubMed ID: 37169516)
1. Epidemiology and a Predictive Model of Prognosis Index Based on Machine Learning in Primary Breast Lymphoma: Population-Based Study.
Yu Y; Xu Z; Shao T; Huang K; Chen R; Yu X; Zhang J; Han H; Song C
JMIR Public Health Surveill; 2023 Jun; 9():e45455. PubMed ID: 37169516
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival.
Peng F; Li J; Mu S; Cai L; Fan F; Qin Y; Ai L; Hu Y
Breast; 2021 Jun; 57():49-61. PubMed ID: 33774459
[TBL] [Abstract][Full Text] [Related]
3. Primary Breast Lymphoma in the United States: 1975-2013.
Thomas A; Link BK; Altekruse S; Romitti PA; Schroeder MC
J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28376147
[TBL] [Abstract][Full Text] [Related]
4. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
[TBL] [Abstract][Full Text] [Related]
5. Primary breast lymphoma in males: Incidence, demographics, prognostic factors, survival, and comparisons with females.
Zhang J; Ma B; Ji H; Guo R
Front Surg; 2022; 9():984497. PubMed ID: 36090327
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.
Xiang N; Dong F; Zhan X; Wang S; Wang J; Sun E; Chen B
BMC Endocr Disord; 2021 Apr; 21(1):68. PubMed ID: 33849490
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Survival Nomograms in Patients with Primary Bladder Lymphoma.
Lin J; Kong J; Luo M; Shen Z; Fang S; Hu J; Xu Z; Dong W; Huang J; Lin T
J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683570
[TBL] [Abstract][Full Text] [Related]
9. Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis.
Mustafa Ali MK; Samhouri Y; Law JY; Khan C; Wegner R; Lee ST; Lister J
Breast Cancer; 2022 Nov; 29(6):1022-1031. PubMed ID: 35788963
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients.
Lin YC; Tsai CH; Wu JS; Huang CS; Kuo SH; Lin CW; Cheng AL
Leuk Lymphoma; 2009 Jun; 50(6):918-24. PubMed ID: 19373599
[TBL] [Abstract][Full Text] [Related]
11. Role of local treatment in primary breast B-cell non-Hodgkin's lymphoma: a propensity score matching-based analysis from SEER database.
Zhang M; Liu N; Wang BY; Zhang J; Zhao A; Yang J; Yang J
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):22-31. PubMed ID: 35049015
[TBL] [Abstract][Full Text] [Related]
12. Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.
Zhu Y; Yang S; He X
J Endocrinol Invest; 2022 Apr; 45(4):815-824. PubMed ID: 34865184
[TBL] [Abstract][Full Text] [Related]
13. Incidence and survival trends in patients with primary tonsillar lymphoma: a large population-based study.
Liang Y; Zhang H; Wu Y; Li M
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4023-4032. PubMed ID: 35397702
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study.
Yhim HY; Kang HJ; Choi YH; Kim SJ; Kim WS; Chae YS; Kim JS; Choi CW; Oh SY; Eom HS; Kim JA; Lee JH; Won JH; Shim H; Lee JJ; Sung HJ; Kim HJ; Lee DH; Suh C; Kwak JY
BMC Cancer; 2010 Jun; 10():321. PubMed ID: 20569446
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Yin X; Xu A; Fan F; Huang Z; Cheng Q; Zhang L; Sun C; Hu Y
Front Oncol; 2019; 9():1198. PubMed ID: 31781500
[No Abstract] [Full Text] [Related]
16. Primary Colorectal Lymphoma: Institutional Experience and Review of a National Database.
Hangge PT; Calderon E; Habermann EB; Glasgow AE; Mishra N
Dis Colon Rectum; 2019 Oct; 62(10):1167-1176. PubMed ID: 30489325
[TBL] [Abstract][Full Text] [Related]
17. The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study.
Xiao J; Mo M; Wang Z; Zhou C; Shen J; Yuan J; He Y; Zheng Y
JMIR Med Inform; 2022 Feb; 10(2):e33440. PubMed ID: 35179504
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma in the United States, 1975-2017.
Lv C; Wang J; Zhou M; Xu JY; Chen B; Wan Y
Ther Adv Hematol; 2022; 13():20406207211066166. PubMed ID: 35096360
[TBL] [Abstract][Full Text] [Related]
19. Global Incidence and Mortality of Gastric Cancer, 1980-2018.
Wong MCS; Huang J; Chan PSF; Choi P; Lao XQ; Chan SM; Teoh A; Liang P
JAMA Netw Open; 2021 Jul; 4(7):e2118457. PubMed ID: 34309666
[TBL] [Abstract][Full Text] [Related]
20. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.
Martinelli G; Ryan G; Seymour JF; Nassi L; Steffanoni S; Alietti A; Calabrese L; Pruneri G; Santoro L; Kuper-Hommel M; Tsang R; Zinzani PL; Taghian A; Zucca E; Cavalli F
Ann Oncol; 2009 Dec; 20(12):1993-9. PubMed ID: 19570964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
